retatrutide para que serve A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity | European Journal of Clinical Pharmacology Product page for Retatrutide /
Description
magnification x20
doi: 10.1111/j.1463-1326.2010.01204.x
View at Publisher | View at Google Scholar Smolen JS, Aletaha D
Regulatory and FDA Considerations The regulatory landscape for GLP-1 weight loss medications has been evolving
These signals converge in the nucleus of the tractus solitarius (NTS) of the brainstem and are integrated with information from higher brain centres relaying reward drive and mood to regulate appetite and control energy expenditure
The exact cause of NAION isnt clear, but its believed to be caused by reduced blood flow to the optic nerve head
